Dec. 31 at 4:32 PM
🚨
$NDRA is advancing non-invasive liver diagnostics with real-world clinical traction!
🔹New feasibility study shows Taeus’ thermo-acoustic fat fraction (TAFF) closely tracks MRI-PDFF at key liver fat thresholds (12–17%, 20–22%)
🔹TAEUS offers a low-cost, scalable alternative to MRI, tested across 40 subjects with BMI 21–47
🔹Strong potential as a practical screening tool for pharma trials and primary care workflows
Watching for continuation above
$4.65 as descending triangle nears apex
(RSI recovering, volume cooling, setup tightening)
Communicated Disclaimer – https://chartingdaily.com/liver-health-breakthrough
Other stocks moving today:
$INBS $NCL $ANGH $DVLT